The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases.
 
Luke Maese
Honoraria - Jazz Pharmaceuticals
Consulting or Advisory Role - Jazz Pharmaceuticals
 
Rachel E. Rau
Consulting or Advisory Role - Jazz Pharmaceuticals
 
Elizabeth A. Raetz
Research Funding - Pfizer (Inst)
Other Relationship - Celgene; Celgene
 
Tong Lin
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Pil Kim
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Reddy Chandula
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Sherrie McClung
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Julie Gray
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
L. Mi Rim Choi
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Mignon L. Loh
Consulting or Advisory Role - MediSix Therapeutics
 
Peter C. Adamson
Stock and Other Ownership Interests - Gilead Sciences; McKesson; Merck; Molina Healthcare; Thermo Fisher Scientific; UnitedHealthcare
Consulting or Advisory Role - Adaptive Biotechnologies
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cancer Prevention Pharmaceuticals (Inst); Celator (Inst); Celgene (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst); Seagen (Inst); SpringWorks Therapeutics (Inst); Takeda (Inst); United Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer; BTG; Celgene/Jazz; Daiichi Sankyo; Pfizer; Sanofi